RBM23 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.535200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.955200E-01
Normal-vs-Stage2
4.135200E-01
Normal-vs-Stage3
2.515700E-02
Normal-vs-Stage4
8.078400E-01
Stage1-vs-Stage2
1.659030E-01
Stage1-vs-Stage3
5.134000E-02
Stage1-vs-Stage4
7.156800E-01
Stage2-vs-Stage3
3.798200E-02
Stage2-vs-Stage4
5.917400E-01
Stage3-vs-Stage4
1.084780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.869600E-01
Normal-vs-AfricanAmerican
7.931400E-01
Normal-vs-Asian
1.039360E-01
Caucasian-vs-AfricanAmerican
8.031400E-01
Caucasian-vs-Asian
1.235000E-01
AfricanAmerican-vs-Asian
1.181010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.252000E-01
Normal-vs-Female
6.887200E-01
Male-vs-Female
8.708200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.953800E-01
Normal-vs-Age(41-60Yrs)
9.597400E-01
Normal-vs-Age(61-80Yrs)
5.287000E-01
Normal-vs-Age(81-100Yrs)
2.945400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.208800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.019800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.097700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.092100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.631700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.608200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.418000E-02
Normal-vs-Daily Drinker
6.936600E-01
Normal-vs-Weekly Drinker
4.241800E-01
Normal-vs-Occasional Drinker
9.768400E-01
Normal-vs-Social Drinker
9.451000E-01
Non Drinker-vs-Daily Drinker
6.528200E-02
Non Drinker-vs-Weekly Drinker
2.980600E-01
Non Drinker-vs-Occasional Drinker
4.337600E-02
Non Drinker-vs-Social Drinker
6.953600E-02
Daily Drinker-vs-Weekly Drinker
5.248000E-01
Daily Drinker-vs-Occasional Drinker
4.874000E-01
Daily Drinker-vs-Social Drinker
6.160400E-01
Weekly Drinker-vs-Occasional Drinker
2.685400E-01
Weekly Drinker-vs-Social Drinker
3.318800E-01
Occasional Drinker-vs-Social Drinker
8.699000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.976000E-01
Normal-vs-Grade 2
9.154800E-01
Normal-vs-Grade 3
8.567200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.910400E-02
Grade 1-vs-Grade 3
1.426560E-01
Grade 1-vs-Grade 4
4.976000E-01
Grade 2-vs-Grade 3
1.694160E-01
Grade 2-vs-Grade 4
9.154800E-01
Grade 3-vs-Grade 4
8.567200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.299600E-01
Normal-vs-NonDiabetic
6.752000E-01
Diabetic-vs-NonDiabetic
2.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.336320E-02
Normal-vs-NoPancreatitis
6.565200E-01
Pancreatitis-vs-NoPancreatitis
3.079000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.783800E-01
Normal-vs-N1
4.454200E-01
N0-vs-N1
2.787000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.993400E-01
Normal-vs-TP53-NonMutant
8.444400E-01
TP53-Mutant-vs-TP53-NonMutant
1.827590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
